Concourse Financial Group Securities, Inc. Gelesis Holdings, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.56 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.11 - $0.52 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.22 - $0.51 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.08 - $1.34 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
N/A
0 New
0 $0
Q1 2022

May 09, 2022
BUY
N/A
0 New
0 $0

Others Institutions Holding GLS

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0
View Full List

About GELESIS HOLDINGS, INC.

GLS Quotes by TradingView
  • Ticker GLS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,946,704
  • Market Cap $1.46M
  • Description
  • Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...
More about GLS
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email